Detalhe da pesquisa
1.
Unraveling the diversity and functions of tissue-resident plasma cells.
Nat Immunol
; 25(2): 330-342, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38172260
2.
The influence of immunodeficiency, disease features, and patient characteristics on survival in plasmablastic lymphoma.
Blood
; 143(2): 152-165, 2024 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37832030
3.
Low mortality in vaccinated immunocompromised haematology patients infected with SARS-CoV-2.
Intern Med J
; 52(12): 2172-2175, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36436197
4.
Excellent outcomes of transformed lymphomas in the rituximab era without autologous stem cell transplantation: an Australian single-centre experience.
Intern Med J
; 51(11): 1825-1834, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32609419
5.
IMiDs prime myeloma cells for daratumumab-mediated cytotoxicity through loss of Ikaros and Aiolos.
Blood
; 132(20): 2166-2178, 2018 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30228232
6.
Mining the Plasma Cell Transcriptome for Novel Cell Surface Proteins.
Int J Mol Sci
; 19(8)2018 Jul 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-30042348
7.
Two cases of refractory IgG4-related disease successfully treated with tocilizumab.
Ann Hematol
; 101(7): 1593-1594, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35152313
8.
COVID-19 unmasks the critical role of primary healthcare providers in the timely diagnosis of multiple myeloma.
Intern Med J
; 52(5): 885-886, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35538010
9.
Profiling clinical platelet and plasma use to inform blood supply and contingency planning: PUPPY, the prospective utilization of platelets and plasma study.
Transfusion
; 56(10): 2455-2465, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27600298
10.
Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma.
Br J Haematol
; 184(4): 679-682, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29527667
11.
Failure to achieve early disease response is associated with inferior survival in patients with newly diagnosed multiple myeloma.
Br J Haematol
; 182(5): 739-741, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28857117
12.
Acute monocytic leukemia masked by hemolytic anemia and sclerotic lesions.
Ann Hematol
; 95(12): 2081-2082, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27572458
13.
Infusional dose-adjusted epoch plus bortezomib for the treatment of plasmablastic lymphoma.
Ann Hematol
; 95(4): 667-8, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26801792
14.
Targeted Therapy in Acute Lymphoblastic Leukaemia.
J Pers Med
; 11(8)2021 Jul 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34442359
15.
Deep profiling of apoptotic pathways with mass cytometry identifies a synergistic drug combination for killing myeloma cells.
Cell Death Differ
; 27(7): 2217-2233, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31988495
16.
Inter-laboratory discordance of beta-2 microglobulin results: impact on the validity of the international staging system for multiple myeloma.
Br J Haematol
; 166(6): 951-3, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24779958
17.
Chronic Lymphocytic Leukemia-Time to Care for the Survivors.
J Clin Oncol
; : JCO2302738, 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38489567
18.
IRF4 Activity Is Required in Established Plasma Cells to Regulate Gene Transcription and Mitochondrial Homeostasis.
Cell Rep
; 29(9): 2634-2645.e5, 2019 11 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31775034
19.
Pitfalls of immunotherapy: lessons from a patient with CTLA-4 haploinsufficiency.
Allergy Asthma Clin Immunol
; 14: 65, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30377434
20.
DCEP as a bridge to ongoing therapies for advanced relapsed and/or refractory multiple myeloma.
Leuk Lymphoma
; 59(12): 2842-2846, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29616871